Stock CABA CABALETTA BIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Cabaletta Bio, Inc.

Equities

CABA

US12674W1099

Market Closed - Nasdaq
Other stock markets
 21:00:00 07/06/2024 BST 		5-day change 1st Jan Change
10.54 USD -4.36% Intraday chart for Cabaletta Bio, Inc. +3.43% -53.57%
05-15 Cabaletta Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
03-22 HC Wainwright Adjusts Cabaletta Bio's Price Target to $30 From $25, Maintains Buy Rating MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
CABALETTA BIO, INC. Stock Cabaletta Bio, Inc.
 509M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 125B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 108B
BIONTECH SE Stock BioNTech SE
 24.21B -
ARGENX SE Stock argenx SE
 22.78B -
GENMAB A/S Stock Genmab A/S
 17.96B
  1. Stock Market
  2. Equities
  3. CABA Stock
  4. Charts Cabaletta Bio, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW